ADHD treatment outcomes vary significantly between individuals.
Some people respond well to medication, while others experience limited benefits or intolerable side effects.
Neurofeedback offers an alternative approach by addressing underlying brainwave dysregulation rather than focusing solely on neurotransmitter levels.
A randomized sham-controlled clinical trial evaluated neurofeedback compared with placebo training and found meaningful improvements in ADHD symptoms among participants receiving genuine neurofeedback.
https://pubmed.ncbi.nlm.nih.gov/28803030/
Another analysis published in JAMA Psychiatry explores how different treatment approaches influence long-term outcomes in ADHD management.
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827733
Understanding these differences may help clinicians tailor treatment plans to individual patients.
